Impact Biomedical (IBO) Interest Coverage Ratio (2022 - 2026)
Impact Biomedical (IBO) posted Interest Coverage Ratio of 0.21 for Q1 2026, up 75.28% on a QoQ basis from 0.84 in Q3 2025, and up 73.67% year-over-year from 0.12 in Q1 2025.
Impact Biomedical (IBO) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Impact Biomedical's Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 0.21 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 73.67% year-over-year to 0.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.49 (up 97.84% YoY) and the FY2024 annual result came in at 25.83, down 8465.94% from the prior year.
- Interest Coverage Ratio was 0.21 for Q1 2026 at Impact Biomedical, up from 0.84 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.21 in Q1 2026 and bottomed at 97.15 in Q4 2024.
- A 5-year average of 9.77 and a median of 0.97 in 2023 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 91.29% in 2024, while the deepest fall reached 966.2% in 2024.
- Impact Biomedical's Interest Coverage Ratio stood at 10.42 in 2022, then increased by 12.59% to 9.11 in 2023, then slumped by 966.2% to 97.15 in 2024, then surged by 99.14% to 0.84 in 2025, then jumped by 75.28% to 0.21 in 2026.
- Business Quant data shows IBO's Interest Coverage Ratio at 0.21 in Q1 2026, 0.84 in Q3 2025, and 0.9 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | -0.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.21 |
| Sep 30, 2025 | -0.84 |
| Jun 30, 2025 | -0.90 |
| Mar 31, 2025 | -0.79 |
| Dec 31, 2024 | -97.15 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -0.56 |
| Mar 31, 2024 | -0.69 |
| Dec 31, 2023 | -9.11 |
| Sep 30, 2023 | -0.97 |
| Jun 30, 2023 | -0.91 |
| Mar 31, 2023 | -7.95 |
| Dec 31, 2022 | -10.42 |
| Sep 30, 2022 | -9.66 |
| Jun 30, 2022 | -5.40 |